Delta Cargo chooses Opticooler

Written by: Alwyn Brice |
We are interested in the challenges of vaccine distribution

Posted by:

Comment on this article

The safe, reliable and efficient transportation of pharmaceutical products is a key focus for Delta Cargo. To support that goal, the airline has approved the DoKaSch Opticooler RAP container for use on Delta aircraft as part of its cold chain pharma programme for the safe transportation of vaccines.

This state-of-the-art climate-control solution offers pharmaceutical and life science companies a controlled and reliable 2-8°C and 15-25°C options, enabling it to be used for the transportation of vaccines, without the need for dry ice. The Opticooler has a large control panel plus quadruple redundancy for all critical parts, meaning there are back-ups for each feature in case of failure. The large loading compartment easily accommodates five standard Euro pallets or four CP-1 pallets; in addition, the container has a large battery that can operate independently up to 120 hours and which requires just two to four hours' battery charging time.

“The introduction of the Opticooler provides our customers with more choice when looking for reliable container options to support the growing global demand for pharma and vaccine shipments,” explains Shawn Cole, Delta's Vice President — Cargo. “Alongside our joint venture partners, Air France-KLM Cargo, we can now offer our customers a seamless experience across the Atlantic, helping to keep supply chains moving and ensuring the safe delivery of temperature sensitive shipments during the current pandemic.”

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, adds: “This agreement with Delta provides more transport options for shippers of sensitive pharmaceutical goods, which is especially important for the upcoming transport of vaccines against COVID-19. Many of these will require a temperature range between 2°C and 8°C during transport, which is exactly what our Opticooler is made for. Delta further expands our extensive global network which allows us to offer our temperature-controlled packaging solutions at even more locations.”

This material is protected by The Airports Publishing Network Ltd copyright see Terms and Conditions.
One-off usage is permitted but bulk copying is not. For multiple copies contact

We are interested in the challenges of vaccine distribution

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code